DAFNA Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-34,800
| Closed | -$443K | – | 87 |
|
|
2015
Q1 | $443K | Buy |
+34,800
| New | +$443K | 0.34% | 49 |
|
|
2014
Q3 | – | Sell |
-92,400
| Closed | -$1.42M | – | 63 |
|
|
2014
Q2 | $1.42M | Sell |
92,400
-7,600
| -8% | -$117K | 1.35% | 20 |
|
|
2014
Q1 | $1.7M | Buy |
100,000
+56,000
| +127% | +$954K | 1.46% | 17 |
|
|
2013
Q4 | $570K | Sell |
44,000
-30,100
| -41% | -$390K | 0.59% | 36 |
|
|
2013
Q3 | $748K | Sell |
74,100
-2,900
| -4% | -$29.3K | 0.82% | 32 |
|
|
2013
Q2 | $575K | Buy |
+77,000
| New | +$575K | 0.84% | 33 |
|